InVitria
InVitria公司 InVitria代理 InVitria一級(jí)代理 InVitria授權(quán)簽約代理
LysoSure,重組人溶菌酶,rhLIF,Lacromin
?
Ventria Bioscience的分公司InVitria 成立的目標(biāo)是為生物技術(shù)行業(yè)提供創(chuàng)新產(chǎn)品，以改善細(xì)胞培養(yǎng)和生物制造。InVitria通過(guò)允許客戶從其基于細(xì)胞的過(guò)程中消除動(dòng)物成分來(lái)實(shí)現(xiàn)這一點(diǎn)。拆除這些組件有助于提高一致性，安全性和效率。InVitria的產(chǎn)品是在我們位于堪薩斯州Junction City的生產(chǎn)設(shè)施中生產(chǎn)的重組蛋白。這些產(chǎn)品在生命科學(xué)行業(yè)有很多用途，包括再生醫(yī)學(xué)，細(xì)胞治療，生物制造，疫苗，診斷和醫(yī)療設(shè)備。
?
諸如胎牛血清（FBS），牛和人血清白蛋白以及牛和人轉(zhuǎn)鐵蛋白的動(dòng)物組分已經(jīng)在許多生物過(guò)程中成為流行的成分，但是在二十世紀(jì)九十年代，科學(xué)家開(kāi)始尋找清除血清和其它動(dòng)物產(chǎn)品的方法關(guān)注產(chǎn)品質(zhì)量，安全和動(dòng)物管理。動(dòng)物產(chǎn)品是不受歡迎的，因?yàn)樗鼈兙哂袀鞑ジ腥拘晕镔|(zhì)如朊病毒（瘋牛?。┖筒《荆℉IV）的風(fēng)險(xiǎn)。另外，動(dòng)物組分和血液衍生產(chǎn)品是不確定的，導(dǎo)致批次間的高度差異。由于這些原因，美國(guó)食品和藥物管理局（FDA），歐洲藥品管理局（EMA）和其他監(jiān)管機(jī)構(gòu)不鼓勵(lì)使用這些動(dòng)物成分。
?
迄今為止，InVitria已經(jīng)開(kāi)發(fā)并商業(yè)化了8種重組蛋白和細(xì)胞培養(yǎng)基補(bǔ)充劑。InVitria的產(chǎn)品開(kāi)發(fā)團(tuán)隊(duì)有一個(gè)積極的計(jì)劃來(lái)根據(jù)客戶的需求擴(kuò)大這個(gè)產(chǎn)品線。
?
在InVitria，我們?yōu)槲覀兊膱F(tuán)隊(duì)和我們的合作伙伴感到自豪。
?
InVitria的團(tuán)隊(duì)致力于為當(dāng)今最緊迫的細(xì)胞培養(yǎng)挑戰(zhàn)提供創(chuàng)新解決方案。
?
“幫助客戶整合這些無(wú)動(dòng)物成分免費(fèi)產(chǎn)品，以改善他們的流程，并達(dá)到他們的商業(yè)目標(biāo)是什么激勵(lì)我InVitria”
?
- ?史蒂夫·佩蒂特，博士。細(xì)胞培養(yǎng)主任
?
“我喜歡與負(fù)責(zé)批準(zhǔn)InVitria作為供應(yīng)商的客戶審計(jì)師合作。他們來(lái)自世界上一些最成功的生物制藥和生命科學(xué)公司，所以他們的期望很高。我們的期望也很高，并導(dǎo)致成功的結(jié)果?！?/p>
?
- ?質(zhì)量總監(jiān)Pat Smith
?
作為Ventria Bioscience的一個(gè)部門，InVitria可以使用Ventria董事會(huì)及其專業(yè)知識(shí)和成功歷史。這些領(lǐng)導(dǎo)人包括：
?
美國(guó)國(guó)家科學(xué)院院士和2003年生物技術(shù)遺產(chǎn)獎(jiǎng)得主，
前世界較大的植物生物技術(shù)公司董事長(zhǎng)兼首席執(zhí)行官，
Chiron公司（現(xiàn)為諾華）的兩位創(chuàng)始人，
前強(qiáng)生公司診斷業(yè)務(wù)總裁，
PRA國(guó)際主席，的臨床試驗(yàn)CRO，
密理博生物科學(xué)部門的前任總裁
的醫(yī)療風(fēng)險(xiǎn)投資公司的兩個(gè)普通合伙人。
Ventria董事會(huì)擁有超過(guò)120年的生物技術(shù)經(jīng)驗(yàn)，擁有145項(xiàng)專利，發(fā)表了600多篇科學(xué)論文。點(diǎn)擊閱讀更多關(guān)于董事會(huì)
?
InVitria與兩家全球分銷商Sigma-Aldrich和Fisher Scientific合作。我們的分銷網(wǎng)絡(luò)還包括北美，歐洲，亞洲和澳大利亞的客戶的幾個(gè)區(qū)域分銷商。這個(gè)廣泛的分銷網(wǎng)絡(luò)為我們的客戶提供完整的采購(gòu)，物流和產(chǎn)品支持選項(xiàng)，以較好地滿足他們的需求。點(diǎn)擊閱讀更多關(guān)于我們的經(jīng)銷商（鏈接到新的經(jīng)銷商頁(yè)面）
?
在InVitria，我們熱愛(ài)我們的產(chǎn)品和我們的客戶。
?
“我們致力于為業(yè)界較大的挑戰(zhàn)提供安全，經(jīng)濟(jì)高效的解決方案：通過(guò)消除動(dòng)物源性成分來(lái)提高生產(chǎn)力和提高一致性”
?
總裁Scott Deeter
?
InVitria與生物制藥公司，大學(xué)，國(guó)家衛(wèi)生研究院和疾病控制中心進(jìn)行了多項(xiàng)研究合作，以加強(qiáng)我們的產(chǎn)品開(kāi)發(fā)和發(fā)現(xiàn)新的產(chǎn)品機(jī)會(huì)。對(duì)于學(xué)術(shù)研究人員，InVitria通過(guò)BioShare計(jì)劃提供支持。
?
在InVitria，我們致力于質(zhì)量和安全。
?
作為Ventria Bioscience的一部分，InVitria利用Ventria公司的專利重組蛋白制造技術(shù)ExpressTec。
?
“ExpressTec為InVitria公司在完全無(wú)動(dòng)物系統(tǒng)中生產(chǎn)重組蛋白提供了一個(gè)安全，實(shí)惠和可持續(xù)的制造平臺(tái)”
?
黃寧博士，研發(fā)副總裁。
?
About InVitria
InVitria –Performance. Defined.
InVitria, a division of?
Ventria Bioscience
, was founded with the goal of providing the biotechnology industry with innovative products to improve cell culture and biomanufacturing. InVitria does this by allowing customers to eliminate animal components from their cell-based processes. Removing these components helps improve consistency, safety and efficiency. InVitria’s products are recombinant proteins that are manufactured in our manufacturing facility in Junction City, Kansas. These products have many uses across the life science industry including in regenerative medicine, cellular therapy, biomanufacturing, vaccines, diagnostics and medical devices.
Animal-components such as fetal bovine serum (FBS), bovine and human serum albumin, and bovine and human transferrin have been popular ingredients in many biological processes, but in the 1990’s scientists began searching for ways to remove serum and other animal products due to concerns about product quality, safety and animal stewardship. Animal products are undesirable because they pose a risk of transmitting infectious agents such as prions (Mad Cow Disease) and virus (HIV). In addition, animal components and blood derived products are undefined leading to high batch-to-batch variation. For these reasons, the Food and Drug Administration (FDA), European Medicines Agency (EMA) and other regulatory bodies discourage use of these animal components.
To date, InVitria has developed and commercialized eight recombinant proteins and cell culture media supplements.?
InVitria’s product development team
?has an active program to expand this product line based on customer needs.
At InVitria, we are proud of our team and our partnerships.
InVitria’s team is committed to providing innovative solutions to the most pressing cell culture challenges today.
“Helping customers integrate these animal component free products to improve their processes and reach their commercial objectives is what excites me about InVitria”
–?
Steve Pettit, Ph.D
. Director, Cell Culture
“I like working with our customer auditors who are responsible for approving InVitria as a vendor. They come from some of the most successful biopharmaceutical and life science companies in the world, so their expectations are high. Our expectations are also high and that leads to a successful outcome.”
–?
Pat Smith
, Director, Quality
As a Division of Ventria Bioscience, InVitria has access to Ventria’s Board of Directors and their expertise and successful history. These leaders include:
- a member of the National Academies of Science and 2003 Biotechnology Heritage Award Winner,
- former Chairman and CEO of the largest plant biotechnology company in the world,
- two founders of Chiron Corporation (now Novartis),
- former President of Johnson & Johnson’s diagnostics business,
- Chairman of PRA International, a leading clinical trial CRO,
- the former President of Millipore’s Bioscience Division, and
- two General Partners of leading healthcare venture capital firms.
Together, the Ventria Board of Directors have amassed over 120 years of biotechnology experience, registered over 145 patents, and published over 600 scientific papers.?
Click to read more about the Board of Directors
InVitria has partnered with two worldwide distributors, Sigma-Aldrich and Fisher Scientific . Our distribution network also includes several regional distributors for customers in North America, Europe, Asia and Australia. This extensive distribution network provides our customers with a full compliment of purchasing, logistics and product support options to best fit their needs. Click to read more about our Distributors (Link to new distributors page)
At InVitria, we are passionate about our products and our customers.
”We are committed to provide safe, cost-effective solutions to the industry’s biggest challenges: improving productivity and enhancing consistency by removing animal derived components”
Scott Deeter
, President
InVitria has several research collaborations with biopharmaceutical companies, leading Universities, the National Institutes of Health and the Centers for Disease Control to further our product development and identify new product opportunities. For academic researchers, InVitria offers support through its
?BioShare program
.
At InVitria, we are dedicated to quality and safety.
As part of Ventria Bioscience, InVitria utilizes Ventria’s patented recombinant protein manufacturing technology called?
ExpressTec
.
“ExpressTec provides a safe, affordable and sustainable manufacturing platform for InVitria to manufacture its recombinant proteins in a completely animal-free system”
Ning Huang
, Ph.D., Vice President Research and Development.
?
?
?
InVitria,的一個(gè)部門Ventria Bioscience,成立的目的,為生物技術(shù)產(chǎn)業(yè)提供創(chuàng)新產(chǎn)品,提高細(xì)胞培養(yǎng)和生物制造。InVitria通過(guò)允許顧客消除動(dòng)物組件從他們的細(xì)胞過(guò)程。刪除這些組件有助于提高一致性、安全性和效率。InVitria的產(chǎn)品是在我們的工廠生產(chǎn)重組蛋白在結(jié)城,堪薩斯州。這些產(chǎn)品有許多使用整個(gè)生命科學(xué)行業(yè)包括再生醫(yī)學(xué)、細(xì)胞療法,為生物疫苗、診斷和醫(yī)療設(shè)備。
Animal-components如胎牛血清的邊后衛(wèi),牛和人血清白蛋白和牛和人類轉(zhuǎn)鐵蛋白一直流行的成分在許多生物過(guò)程,但在1990年代,科學(xué)家們開(kāi)始尋找方法去除血清和其他動(dòng)物產(chǎn)品因擔(dān)心產(chǎn)品質(zhì)量,安全和動(dòng)物管理。動(dòng)物產(chǎn)品是不可取的因?yàn)樗鼈儤?gòu)成傳播傳染性病原體的風(fēng)險(xiǎn)如朊病毒(瘋牛病)和病毒(HIV)。此外,動(dòng)物成分和血液衍生產(chǎn)品定義導(dǎo)致高批次變化。由于這些原因,美國(guó)食品和藥物管理局(FDA),歐洲藥品局(EMA)和其他監(jiān)管機(jī)構(gòu)阻止這些動(dòng)物組件的使用。
迄今為止,InVitria已開(kāi)發(fā)和商業(yè)化8重組蛋白和細(xì)胞培養(yǎng)基補(bǔ)充。
Products
InVitria Cell Culture Supplements
Cellastim S
T Cell Qualified Recombinant Human Serum Albumin
Learn More
Buy Now
Cellastim
Defined, animal-free, recombinant albumin (rHSA)
Learn More
Buy Now
Zap-SR
A cost effective option to reduce serum concentrations in cell culture medium
Learn More
Buy Now
Optiferrin
Defined, animal-free, recombinant human transferrin
Learn More
Buy Now
Optibumin
Recombinant human serum albumin that is intended as a stabilizer, diluent, surgical adhesive and cell culture media component.
Learn More
CALL
Lacromin
Defined, animal-free, recombinant lactoferrin, specifically produced for use as a cell culture media supplement.
Learn More
Buy Now
ITSE Animal-Free
Cell culture media supplement formulated for improved serum reduced or serum free cell growth.
Learn More
Buy Now
rhLIF
A high performance and high quality animal component free stem cell media additive for maintaining pluripotent stem cells.
Learn More
Buy Now
Diagnostics and Assay Development
Food and Feed Additives
溫馨提示：不可用于臨床治療。